Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer-Reference-Cited by-同舟云学术

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

Published:2014-10-20 Issue:4 Volume:121 Page:527-534
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kumar Aalok¹,Kennecke Hagen F.¹,Renouf Daniel J.¹,Lim Howard J.¹,Gill Sharlene¹,Woods Ryan²,Speers Caroline¹,Cheung Winson Y.¹

Affiliation:

1. Division of Medical Oncology; University of British Columbia, British Columbia Cancer Agency; Vancouver British Columbia Canada

2. Cancer Control Research; University of British Columbia, British Columbia Cancer Agency; Vancouver British Columbia Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer;O'Connell;J Clin Oncol,1997

2. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators;Efficacy of adjuvant fluorouracil and folinic acid in colon cancer;Lancet,1995

3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009

4. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089;Voyer;J Clin Oncol,2003

5. Should Dukes' B patients receive adjuvant therapy? A statistical perspective;Buyse;Semin Oncol,2001

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?;Medicina;2024-08-22

2. The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study;Surgery;2024-08

3. Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with ‘persister’ cell profiles fail to benefit from adjuvant chemotherapy;BMJ Oncology;2024-08

4. Prognostic Value of Systemic Inflammatory Response in Lymph Node-Negative Colorectal Cancer;The American Surgeon™;2024-06-17

5. Exploring prognostic values of DNA ploidy, stroma-tumor fraction and nucleotyping in stage II colon cancer patients;Discover Oncology;2024-06-14